Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02530281Phase 3Completed
A Phase 3 trial of glycopyrronium in hyperhidrosis, sponsored by Journey Medical Corporation. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02530281.